These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8727049

  • 21. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
    Fagerström S, Påhlman S, Gestblom C, Nånberg E.
    Cell Growth Differ; 1996 Jun; 7(6):775-85. PubMed ID: 8780891
    [Abstract] [Full Text] [Related]

  • 22. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A, Hallberg B, Fagerström S, Larsson C, Axelson H, Påhlman S.
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [Abstract] [Full Text] [Related]

  • 23. Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor.
    Falcione M, Milligan KD, Schwartz MC, Schor NF.
    Biochem Pharmacol; 1993 Aug 17; 46(4):731-8. PubMed ID: 8363646
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
    Dedoni S, Olianas MC, Ingianni A, Onali P.
    Neuropharmacology; 2014 Apr 17; 79():321-34. PubMed ID: 24333329
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
    Tong HX, Lu CW, Zhang JH, Ma L, Zhang JH.
    Chin Med Sci J; 2007 Mar 17; 22(1):38-43. PubMed ID: 17441316
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
    Algarni AS, Hargreaves AJ, Dickenson JM.
    Eur J Pharmacol; 2018 Feb 05; 820():113-129. PubMed ID: 29242118
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC.
    Cancer Res; 1993 Oct 15; 53(20):4978-86. PubMed ID: 8402688
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis.
    Simpson PB, Bacha JI, Palfreyman EL, Woollacott AJ, McKernan RM, Kerby J.
    Anal Biochem; 2001 Nov 15; 298(2):163-9. PubMed ID: 11757502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.